Sort
21,453 grants matching “tuberculosis”
Improving rapid phenotypic drug susceptibility testing for drug resistant tuberculosis in high-burden areas
$887,558Jordi B Torrelles · Texas Biomedical Research Institute · R01 · FY2024 · AI
Sputum Transcriptomic Expression Profiling in Study 31: Express 31
$887,447Payam Nahid · University Of California, San Francisco · R01 · FY2022 · AI
South African Medical Research Council Clinical Trials Unit (MRC CTU)
$887,214Gita Ramjee · Medical Research Council Of South Africa · UM1 · FY2016 · AI
Gene Regulation In The Immune System
$887,060Keiko Ozato · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2015 · HD
Helicobacter pylori Pathogenesis Studies
$887,010William Coleman · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2011 · DK
Enabling point-of-care molecular diagnostics by developing an adaptive PCR instrument and on-demand kit reagents
$886,669Steven John Simmons · Bioventures, Inc. · R42 · FY2018 · HG
Integrating Addiction Treatment and HIV Services into Primary Care Clinics in Ukraine
$886,533Frederick Lewis Altice · Yale University · R01 · FY2016 · DA
A systems analysis of drug tolerance in Mycobacterium tuberculosis
$886,311Nitin S Baliga · Institute For Systems Biology · R01 · FY2023 · AI
Conservation and Sustainable Use of Biodiversity in PNG
$886,075Louis R Barrows · University Of Utah · U01 · FY2009 · TW
The Rv2623-Rv1747 interaction: regulation of the in vivo fate of M. tuberculosis
$885,024John R. Chan · Rbhs-New Jersey Medical School · R01 · FY2022 · AI
Predictors of Resistance Emergence Evaluation in MDR-TB Patients on Treatment (PREEMPT)
$884,552C Robert Horsburgh · Boston University Medical Campus · R01 · FY2019 · AI
Targets in Mycobacterium Tuberculosis: Stress Resistance & Repair
$883,176Carl F Nathan · Weill Medical Coll Of Cornell Univ · R01 · FY2009 · AI
RP3: Targeting ATG gene-dependent immunity for novel anti-infective therapeutics
$882,760Seungmin Hwang · Ut Southwestern Medical Center · U19 · FY2022 · AI
Integrating Addiction Treatment and HIV Services into Primary Care Clinics in Ukraine
$882,615Frederick Lewis Altice · Yale University · R01 · FY2017 · DA
East Africa IEDEA Regional Consortium
$882,409Constantin T Yiannoutsos · Indiana University Indianapolis · U01 · FY2009 · AI
Development of Aersolized Vaccines
$882,379Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis
$881,854Shabaana A. Khader · University Of Chicago · R01 · FY2024 · AI
Closing the Gaps on Buruli Ulcer Diagnosis, Treatment, and Prevention
$881,258Eric L Nuermberger · Johns Hopkins University · R01 · FY2018 · AI
Lactoferrin Modulation of Granuloma Pathology
$881,060Jeffrey K Actor · Pharmareview Corporation · R42 · FY2018 · AI
Innate, Transcriptomic, and Microbiomic correlates of TB infection
$880,842Michael Haggai Glickman · Weill Medical Coll Of Cornell Univ · U19 · FY2016 · AI
Task A07: Anti-mycobacterial Target or Mechanism Identification contract (AToMIc)
$880,685Richard Slayden · Colorado State University · N01 · FY2019 · AI
Clinical Studies
$880,673Molly Forrest Franke · Harvard Medical School · U19 · FY2019 · AI
Husbandry & Management Core
$880,595Gregory Brion Timmel · University Of California At Davis · U42 · FY2025 · OD
Mouse models for paucibacillary persistence
$879,783Sabine Ehrt · Weill Medical Coll Of Cornell Univ · U19 · FY2014 · AI
Structure, function, and regulation of the bacterial transcription cycle
$879,598Seth A Darst · Rockefeller University · R35 · FY2019 · GM